Kingsway Financial Services Inc. — Form 10-Q Summary
Period note: Despite the request metadata identifying 2019 Q1, this filing covers the quarter and nine months ended September 30, 2019. It was signed April 10, 2020, and includes subsequent-event disclosures through early 2020. Amounts below are in U.S. dollars.
Business context and reporting period
Kingsway is a U.S.-based holding company with two reportable segments: Extended Warranty, including vehicle, equipment and home warranty products and services; and Leased Real Estate, which receives rent from a long-term triple-net lease on property in Texas. Mendota’s insurance operations were sold in October 2018 and are reported as discontinued operations in the prior-year comparison.
Financial performance and position
| Metric | Three months ended Sep. 30, 2019 | Nine months ended Sep. 30, 2019 | Comparable 2018 period |
|---|---|---|---|
| Revenue | $16.4 million | $44.9 million | $13.2 million and $38.7 million |
| Operating income (loss) | $0.45 million | $(1.28) million | $1.82 million and $(0.39) million |
| Net loss | $(4.01) million | $(1.21) million | $(3.36) million and $(15.88) million |
| Net loss attributable to common shareholders | $(4.47) million | $(2.64) million | $(3.83) million and $(17.37) million |
| Basic and diluted loss per share | $(0.20) | $(0.12) | $(0.18) and $(0.80) |
| Operating cash flow | Not provided for the quarter | $0.009 million | $(15.30) million for nine months |
- Third-quarter revenue rose about 24%; nine-month revenue rose about 16%. The increase primarily reflects Geminus, acquired March 1, 2019, which contributed $6.8 million of revenue and $0.6 million of net income from acquisition through September 30.
- Extended Warranty segment operating income was $1.6 million for the quarter and $3.2 million year to date; Leased Real Estate segment operating income was $0.8 million and $2.0 million, respectively. These are segment measures, not consolidated GAAP operating income.
- The quarterly loss from continuing operations widened year over year, notably reflecting a $3.4 million fair-value loss on limited liability investments and higher unallocated interest and other expenses. The nine-month net loss improved substantially from 2018, which included discontinued-operation disposal losses.
- Net cash and restricted cash from continuing operations increased $2.3 million during the nine months to $33.8 million. Investing activities used $1.6 million, including the Geminus acquisition; financing activities provided $3.9 million, including net bank-loan proceeds.
- At September 30, total assets were $402.4 million, total liabilities $375.7 million, and shareholders’ equity $20.2 million. Debt carrying value was $257.2 million: $10.8 million of bank loans, $195.8 million of notes payable and $50.6 million of subordinated debt. Deferred trust-preferred interest of $7.4 million was included in accrued liabilities.
- Consolidated cash and cash equivalents were $13.1 million, with another $20.8 million restricted. Holding-company liquidity was only $1.9 million, described as approximately four months of recurring operating expenses; subsidiary cash is generally not freely available to the holding company.
Changes, outlook, risks and unusual items
- Geminus was acquired for $8.4 million, including an installment payable, funded largely with a $10.0 million bank loan bearing interest at LIBOR plus 9.25%. Goodwill of $7.4 million was recognized.
- The company deferred interest on its trust-preferred securities beginning in 2018, a contractual right that the filing says is not a default. Management’s later liquidity discussion says it projected insufficient legally available funds to both pay accumulated deferred interest and redeem preferred shares on April 1, 2021. It described possible negotiations with preferred holders, capital raising and monetization of non-core investments. Management expected operating needs for the next twelve months to be met, excluding those redemption and deferred-interest obligations; that assessment was subject to risks, including COVID-19.
- COVID-19 developments disclosed after the reporting date included lower vehicle warranty sales and expected pressure on home warranty enrollments. A March 2020 review resulted in a $0.7 million write-down of a private-company investment; management warned of possible further investment, goodwill and intangible-asset impairments.
- Contingencies include a CMC-related lawsuit whose potential exposure was not reasonably estimable, and indemnification obligations related to the Mendota sale. A January 2020 Aegis settlement required a $0.9 million payment plus reimbursement of 60% of certain future losses, capped at $4.8 million. A later Mendota claim settlement was estimated to cause a $1.6 million loss, funded from escrow.
- Disclosure controls and procedures were deemed ineffective as of September 30, 2019 because of material weaknesses involving complex transactions, accounting and disclosures, receivable collectability, investment impairment and account reconciliations. Remediation was underway but not yet complete or tested as effective. The filing also marks “No” for having filed all required reports during the preceding 12 months.
- No specific earnings or revenue guidance is provided. Management’s outlook is qualified by economic uncertainty, liquidity constraints and COVID-19-related risks.
Important facts for investors to verify
- Confirm the filing’s actual period (quarter ended September 30, 2019), late filing context and the “No” response regarding timely filing of required reports.
- Track holding-company cash availability separately from consolidated and restricted cash, plus compliance with subsidiary distribution limits.
- Assess the trust-preferred interest deferral, preferred-share redemption terms and the company’s ability to meet obligations when due.
- Review remediation and independent testing of the disclosed material weaknesses, and any subsequent corrections or restatements.
- Monitor the CMC litigation, Aegis and Mendota indemnity/settlement exposures, COVID-19 effects, and valuation of significant investments and goodwill.
- Separate underlying segment operating performance from investment fair-value changes, corporate costs and prior-year discontinued-operation effects.